Aydin H. Harston
Professional Bio
Aydin Harston combines his love for science and technology with legal expertise to advocate for his clients in all matters necessary to grow, protect, and defend their businesses. With a Ph.D. in biochemistry and numerous scientific and legal publications, Aydin seeks to produce creative and effective approaches to achieve his clients' goals as efficiently as possible.
Time to Rethink “Consisting Essentially of” as a Claim Limitation
Biosimilars Law Bulletin ·
FDA Approves Four Biosimilars During Summer 2019 While Europe is on Vacation
Biosimilars Law Bulletin ·
House Democrats Seek to Remove Biologics Exclusivity Period From USMCA
Biosimilars Law Bulletin ·
What Pharma Companies Must Do Globally to Benefit From Canada’s Patent Term Extension Framework
Biosimilars Law Bulletin ·